Ablynx NV - Strategic SWOT Analysis Review

December 2021 | 25 pages | ID: AAD7EBCA7D7EN
GlobalData

Abstracts

Ablynx NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Ablynx NV (Ablynx), a subsidiary of Sanofi, is a biopharmaceutical company that focuses on developing Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. The company has a portfolio of Nanobody-based therapeutic programs in various vital disease areas, including inflammation, hematology, immuno-oncology and oncology. The company’s proprietary Nanobody platform allows the rapid generation and large-scale production of novel biological therapeutics that have potential to be used in a wide range of human diseases. The company has research collaborations and significant partnerships with key pharmaceutical companies including Merck, Novartis and Boehringer Ingelheim. Ablynx is headquartered in Ghent, Belgium.

Ablynx NV Key Recent Developments

Jul 15,2021: LabGenius announces research collaboration with Ablynx, a sanofi company

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Ablynx NV - Key Facts
Ablynx NV - Key Employees
Ablynx NV - Key Employee Biographies
Ablynx NV - Major Products and Services
Ablynx NV - History
Ablynx NV - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Ablynx NV - Business Description
Ablynx NV - SWOT Analysis
SWOT Analysis - Overview
Ablynx NV - Strengths
Ablynx NV - Weaknesses
Ablynx NV - Opportunities
Ablynx NV - Threats
Ablynx NV - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Ablynx NV, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ablynx NV, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ablynx NV, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Jul 15, 2021: LabGenius announces research collaboration with Ablynx, a sanofi company

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Ablynx NV, Key Facts
Ablynx NV, Key Employees
Ablynx NV, Key Employee Biographies
Ablynx NV, Major Products and Services
Ablynx NV, History
Ablynx NV, Subsidiaries
Ablynx NV, Key Competitors
Ablynx NV, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ablynx NV, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Ablynx NV, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Ablynx NV, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Ablynx NV, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021